skip to content
Systematic Reviews of Treatments for Cancer of the Uterus
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for uterine cancer.
Updated February 2010
7 Resources Found
Results 1 to 7 displayed.
| Title: | High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Improved survival and local control rate have made the combination of external beam radiotherapy (EBRT) and intracavitary brachytherapy (ICBT) the standard treatment for locally advanced uterine cervix cancer. The use of high dose rate (HDR) brachythera... |
| Date: | Jun 2010 |
| Title: | Lymphadenectomy for the management of endometrial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Cancer arising from the lining of the womb, known as endometrial carcinoma, is now the most common gynaecological cancer in western Europe and North America. Most women (75%) still have their tumour confined to the body of the womb at diagnosis and thre... |
| Date: | Jun 2009 |
| Title: | Hormone therapy in postmenopausal women and risk of endometrial hyperplasia |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Hormone therapy may be used to manage troublesome menopausal symptoms, but is currently recommended to be given at the lowest effective dose and regularly reviewed by a woman and her doctor. In women with an intact uterus hormone therapy comprising estr... |
| Title: | Adjuvant radiotherapy for stage I endometrial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Women with stage I endometrial cancer have a low risk of recurrence of their disease. About 10% of women treated with surgery alone have a recurrence. This risk is significantly higher (and maybe double) for some women with high risk factors including g... |
| Date: | Feb 2007 |
| Title: | Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | These women have a poor prognosis. Giving extra drugs seems to reduce disease progression by a small amount. However, it does not seem to allow women to live longer. Also, more chemotherapy seems to cause a greater amount of serious short-term side effe... |
| Date: | Jun 2005 |
| Title: | Progestagens for endometrial cancer |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | No evidence to support use of adjuvant progestagens to prevent recurrence of endometrial cancer after surgery. Endometrial cancer is becoming the most common genital tract cancer in many western countries. Progestagen (a hormone) therapy is sometimes us... |
| Date: | Feb 2002 |
| Title: | Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Smooth muscle tumours of the uterus (uterine fibroids)are usually asymptomatic, however up to 50% cause symptoms severe enough to warrant therapy, and surgery is the standard treatment. Fibroid growth is stimulated by the hormone oestrogen and gonadotro... |
Results 1 to 7 displayed.
